Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · IEX Real-Time Price · USD
0.752
-0.004 (-0.48%)
At close: Apr 30, 2024, 4:00 PM
0.764
+0.012 (1.54%)
After-hours: Apr 30, 2024, 7:56 PM EDT
Cara Therapeutics Market Cap
Cara Therapeutics has a market cap or net worth of $41.10 million as of April 30, 2024. Its market cap has decreased by -81.42% in one year.
Market Cap
41.10M
Enterprise Value
-16.89M
1-Year Change
-81.42%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since January 31, 2014, Cara Therapeutics's market cap has decreased from $282.00M to $41.10M, a decrease of -85.42%. That is a compound annual growth rate of -17.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 29, 2024 | 41.30M | 10.43% |
Apr 26, 2024 | 37.40M | -2.35% |
Apr 25, 2024 | 38.30M | 4.36% |
Apr 24, 2024 | 36.70M | -4.92% |
Apr 23, 2024 | 38.60M | -3.26% |
Apr 22, 2024 | 39.90M | 10.53% |
Apr 19, 2024 | 36.10M | -4.24% |
Apr 18, 2024 | 37.70M | -5.75% |
Apr 17, 2024 | 40.00M | 3.09% |
Apr 16, 2024 | 38.80M | - |
Apr 15, 2024 | 38.80M | -7.18% |
Apr 12, 2024 | 41.80M | -5.64% |
Apr 11, 2024 | 44.30M | -0.23% |
Apr 10, 2024 | 44.40M | -2.42% |
Apr 9, 2024 | 45.50M | 0.89% |
Apr 8, 2024 | 45.10M | -5.65% |
Apr 5, 2024 | 47.80M | 5.99% |
Apr 4, 2024 | 45.10M | -9.07% |
Apr 3, 2024 | 49.60M | -1.20% |
Apr 2, 2024 | 50.20M | 1.01% |
Apr 1, 2024 | 49.70M | - |
Mar 28, 2024 | 49.70M | 4.63% |
Mar 27, 2024 | 47.50M | 19.05% |
Mar 26, 2024 | 39.90M | -10.94% |
Mar 25, 2024 | 44.80M | -7.25% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Ocuphire Pharma | 41.94M |
Cyclo Therapeutics | 41.39M |
Rapid Micro Biosystems | 40.78M |
Aspira Women's Health | 40.74M |
ReWalk Robotics | 40.32M |
iCAD, Inc. | 39.79M |
ImmuCell | 39.76M |
Carmell Therapeutics | 39.22M |